Login / Signup

Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias.

Ekaterina RebmannNaomi A PorretMartin AndresGertrud WiedemannYara BanzMyriam LegrosMatthias PollakElisabeth Oppliger LeibundgutThomas PabstUlrike Bacher
Published in: BMC medical genomics (2022)
The probability of detecting a mutation by NGS in the BM was highest in samples with > 10% clonal PC by MFC, or > 20% PC by BMC/ BMH. We propose further evaluation of these thresholds as a practical cut-off for processing of samples by NGS at initial PCD diagnosis.
Keyphrases
  • single cell
  • cell therapy
  • stem cells
  • clinical evaluation